Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
NVCT holding history
Nuvectis Pharma, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVCT overviewAll 13F holders of NVCTFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,721
- Value
- $344.3K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,721 | $344.3K | <0.1% | −3,847−17.0% | Reduced | Holders |
| Q1 2026 | 22,568 | $174.5K | <0.1% | −5,443−19.4% | Reduced | Holders |
| Q4 2025 | 28,011 | $211.5K | <0.1% | +9,494+51.3% | Added | Holders |
| Q3 2025 | 18,517 | $111.5K | <0.1% | −6,176−25.0% | Reduced | Holders |
| Q2 2025 | 24,693 | $184.5K | <0.1% | +17,716+253.9% | Added | Holders |
| Q1 2025 | 6,977 | $68.2K | <0.1% | +4,658+200.9% | Added | Holders |
| Q4 2024 | 2,319 | $12.5K | <0.1% | −29−1.2% | Reduced | Holders |
| Q3 2024 | 2,348 | $14.8K | <0.1% | −7,850−77.0% | Reduced | Holders |
| Q2 2024 | 10,198 | $64.6K | <0.1% | −30,993−75.2% | Reduced | Holders |
| Q1 2024 | 41,191 | $337.8K | <0.1% | +18,276+79.8% | Added | Holders |
| Q4 2023 | 22,915 | $191.1K | <0.1% | +19,436+558.7% | Added | Holders |
| Q3 2023 | 3,479 | $44.8K | <0.1% | −1,624−31.8% | Reduced | Holders |
| Q2 2023 | 5,103 | $81.5K | <0.1% | +1,988+63.8% | Added | Holders |
| Q1 2023 | 3,115 | $40.8K | <0.1% | +2,814+934.9% | Added | Holders |
| Q4 2022 | 301 | $2.26K | <0.1% | +100+49.8% | Added | Holders |
| Q3 2022 | 201 | $1.00K | <0.1% | +1+0.5% | Added | Holders |
| Q2 2022 | 200 | $2.00K | <0.1% | +200 | New | Holders |